🇺🇸 FDA

Company profile · Sponsor

Rare

Rare Thyroid Therapeutics International AB

E7C7AD0 · EMA pharma EU
Pipeline
2
Drugs
0
Patents
0

Quick answer

Rare (E7C7AD0) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E7C7AD0
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (2)

Search pipeline →

  1. Tiratricol, Matching placebo (for participants allocated to the placebo group in the Randomized Treatment Period)

    Rare

    Monocarboxylate Transporter 8 (MCT8) deficiency

    phase 3 small molecule active

    1 trial

  2. Tiratricol, Tiratricol

    Rare

    Monocarboxylate Transporter 8 (MCT8) deficiency

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Rare?

Rare (E7C7AD0) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Rare sponsor?

We track 2 ClinicalTrials.gov-linked programs for Rare, including Tiratricol, Matching placebo (for participants allocated to the placebo group in the Randomized Treatment Period) and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Rare company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.